|
|
Subscribe
to our newsletter:
| |
|
|
|
|
Search results for: eba
1 - 5 of 60 <<previous | next>>
Drugs results:
|
Oxycontin, also called Oxycodone is a Narcotic Analgesic used to treat pain. Oxycontin works in the central nervous system (CNS) to relieve pain.
Be sure to tell your doctor of any allergies you have whether it is to medication or food, preservatives, more...
|
|
Oxycodone, sometimes called Oxycontin is a Narcotic Analgesic used to treat pain. Oxycontin works in the central nervous system (CNS) to relieve pain.
Be sure to tell your doctor of any allergies you have whether it is to medication or food, preservati more...
|
|
Combination medicines like Percocet contain narcotic analgesics (Oxycodone) and Acetaminophen, and are used to relieve pain. This combination may provide better pain relief than either medicine used alone. In some cases, relief of pain may come at lower d more...
|
|
Donepezil is used to treat symptomatic mild to moderately severe Alzheimer's disease and vascular dementia (associated with cerebrovascular disease). Alzheimer's disease is associated with low levels of a chemical called acetylcholine in your brain. The more...
|
|
Isotretinoin is a form of vitamin A which works by decreasing the rate of sebum (oil) production by the sebaceous or oil glands hence, it is used to treat severe forms of acne such as nodular and cystic acne & acne conglobata that has not responded to ant more...
|
Diseases results:Pain relief
Fever
Alzheimers disease
Skin diseases
Acne
Irregular heartbeat
Mouth diseases
Allergic conjunctivitis
PharyngitisArticles results:
| Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines |
On Monday 13 November, the Biotech industry will call on the WHO to address the naming (1) of biologicals including biosimilar medicines in the interests of patients and public health at the upcoming meeting for stakeholders organised by the WHO in Geneva (November 13, 2006).EuropaBio welcomes this opportunity by the WHO and the international community to discuss and debate the issues related to the naming of biologicals and biosimilar medicines.
|
| FDA Reaches Tentative Agreement With Pharmaceutical Companies On User Fees To Review Advertisements |
FDA has reached an agreement with the pharmaceutical industry that would require companies to pay fees to the agency for evaluating television advertisements in exchange for quicker reviews of the ads, the Wall Street Journal reports. Under the agreement, pharmaceutical companies would pay FDA $40,000 to $50,000 at the beginning of each year for each television ad campaign they planned to air.
|
| Food And Drug Law Institute Sponsors National Colloquium On Access To Unapproved Drugs |
Should terminally ill patients be allowed access to drugs not approved by the Food and Drug Administration? That is the question a panel of experts will discuss and debate at a landmark Colloquium, Whose Life Is It, Anyway?, sponsored by the Food and Drug Law Institute (FDLI), Feb. 27, 2007, in Washington, D.C. This meeting is the first in a series of colloquia to be sponsored by FDLI in upcoming months.
|
1 - 5 of 60 <<previous | next>>
|
|
|
